AMRI Names William S. Marth as President and CEO

Albany Molecular Research, Inc. 

, a leading global contract research and manufacturing organization, announced that Thomas E. D'Ambra, Ph.D. will retire as President and Chief Executive Officer of the Company, effective December 31, 2013. Dr. D'Ambra will be named the Company's non-executive Chairman of the Board of Directors on the same date. Dr. D'Ambra will be succeeded as President and CEO by Mr. , currently non-executive Chairman of the AMRI Board, effective January 1, 2014. Mr. Marth will remain a member of the Company's Board of Directors.